OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Bispecific Antibodies: A Smart Arsenal for Cancer Immunotherapies
Gihoon You, Jonghwa Won, Yangsoon Lee, et al.
Vaccines (2021) Vol. 9, Iss. 7, pp. 724-724
Open Access | Times Cited: 37
Gihoon You, Jonghwa Won, Yangsoon Lee, et al.
Vaccines (2021) Vol. 9, Iss. 7, pp. 724-724
Open Access | Times Cited: 37
Showing 26-50 of 37 citing articles:
Cancer Vaccines and Immunotherapy for Tumor Prevention and Treatment
Jagmohan Singh, Wilbur B. Bowne, Adam E. Snook
Vaccines (2021) Vol. 9, Iss. 11, pp. 1298-1298
Open Access | Times Cited: 13
Jagmohan Singh, Wilbur B. Bowne, Adam E. Snook
Vaccines (2021) Vol. 9, Iss. 11, pp. 1298-1298
Open Access | Times Cited: 13
Multiantigen T-Cell Hybridizers: A Two-Component T-Cell-Activating Therapy
M. Tommy Gambles, Shannuo Li, Isaac Kendell, et al.
ACS Nano (2024) Vol. 18, Iss. 34, pp. 23341-23353
Closed Access | Times Cited: 1
M. Tommy Gambles, Shannuo Li, Isaac Kendell, et al.
ACS Nano (2024) Vol. 18, Iss. 34, pp. 23341-23353
Closed Access | Times Cited: 1
Targeting mutant p53: a key player in breast cancer pathogenesis and beyond
Hina Qayoom, Burhan Ul Haq, Shazia Sofi, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Hina Qayoom, Burhan Ul Haq, Shazia Sofi, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Bispecific Antibodies, Immune Checkpoint Inhibitors, and Antibody−Drug Conjugates Directing Antitumor Immune Responses: Challenges and Prospects
C. Li, Xin Yuan, Ping Yi
Cell Biochemistry and Function (2024) Vol. 42, Iss. 8
Open Access | Times Cited: 1
C. Li, Xin Yuan, Ping Yi
Cell Biochemistry and Function (2024) Vol. 42, Iss. 8
Open Access | Times Cited: 1
Enhanced immunogenic potential of cancer immunotherapy antibodies in human IgG1 transgenic mice
Jérôme Egli, Stefan Heiler, Felix Weber, et al.
mAbs (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Jérôme Egli, Stefan Heiler, Felix Weber, et al.
mAbs (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Imaging the pharmacokinetics and therapeutic availability of the bispecific CD3xTRP1 antibody in syngeneic mouse tumor models
Gerwin W. Sandker, Jim Middelburg, Evienne Wilbrink, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Gerwin W. Sandker, Jim Middelburg, Evienne Wilbrink, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Double hit — bispecific antibodies in cancer therapy
Alicja Bogdanowicz, Kamila Wojas‐Krawczyk, Natalia Krzyżanowska, et al.
Oncology in Clinical Practice (2024)
Open Access
Alicja Bogdanowicz, Kamila Wojas‐Krawczyk, Natalia Krzyżanowska, et al.
Oncology in Clinical Practice (2024)
Open Access
Revolutionizing cancer treatment: Exploring novel immunotherapeutics, checkpoints, bispecifics, and vaccines in development
Anas Islam, Vijay Singh, Pooja S. Murkute, et al.
Advances in immunology (2024)
Closed Access
Anas Islam, Vijay Singh, Pooja S. Murkute, et al.
Advances in immunology (2024)
Closed Access
Bispecific Antibody-Bound T Cells as a Novel Anticancer Immunotherapy
Jaewon Cho, Nara Tae, Jae-Hee Ahn, et al.
Biomolecules & Therapeutics (2022) Vol. 30, Iss. 5, pp. 418-426
Open Access | Times Cited: 3
Jaewon Cho, Nara Tae, Jae-Hee Ahn, et al.
Biomolecules & Therapeutics (2022) Vol. 30, Iss. 5, pp. 418-426
Open Access | Times Cited: 3
Directing HIV-1 for degradation by non-target cells, using bi-specific single-chain llama antibodies
Jord C. Stam, Steven de Maat, Dorien de Jong, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 2
Jord C. Stam, Steven de Maat, Dorien de Jong, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 2
Advancements in Bispecific Antibody Development and Research Trends
Yong Hwan Choi, Ha Seung Song, Su Keun Lee, et al.
Microbiology and Biotechnology Letters (2023) Vol. 51, Iss. 3, pp. 223-242
Open Access
Yong Hwan Choi, Ha Seung Song, Su Keun Lee, et al.
Microbiology and Biotechnology Letters (2023) Vol. 51, Iss. 3, pp. 223-242
Open Access
